Abstract
Background: Immediately following percutaneous balloon mitral valvuloplasty (PBMVP), patients have a 3% risk of systemic thromboembolism.
Hypothesis: We hypothesized that this may in part be due to an increase in hypercoagulability (as indicated by abnormal coagulation, platelet activation, and endothelial dysfunction) in such patients.
Methods: We measured indices of platelet activation [soluble P‐selectin (sPsel), ELISA], endothelial dysfunction [von Willebrand factor (vWf), ELISA], and coagulation (fibrinogen, modified Clauss) in 16 patients (15 women, mean age 59 ± 10 years) with chronic atrial fibrillation admitted for PBMVP, and 16 healthy age‐ and gender‐matched controls. Blood samples were obtained as follows: (1) peripheral venous samples prior to PBMVP, immediately following PBMVP, and 24 h after PBMVP; and (2) arterial samples prior to and immediately following PBMVP.
Results: Patients with mitral stenosis and chronic atrial fibrillation demonstrated significantly higher mean levels of vWf [148 (SD24) vs. 102 (SD 37); t‐test, p<0.001] and plasma fibrinogen [4.2 (SD 0.8) vs. 3.3 (SD 0.8); p = 0.003] at baseline than matched healthy controls. There was a nonsignificant trend toward lower median sP‐sel levels in patients with mitral stenosis [64 (inter quartile range 47–91) vs. 109 (46–128); Mann‐Whitney test, p = 0.08]. Following PBMVP, there was a significant increase in venous sP‐sel levels immediately post procedure (paired Wilcoxon test, p = 0.03) and at 24 h afterward (p = 0.01). Arterial s‐Psel levels correspondingly increased immediately post procedure (p = 0.008). There was a significant increase in mean venous (at 24 h) but not arterial vWf levels post PBMVP. There were no significant changes in mean venous or arterial plasma fibrinogen levels following PBMVP.
Conclusion: Patients with mitral stenosis and chronic atrial fibrillation have increased plasma levels of vWf and fibrinogen levels compared with healthy controls, suggesting increased endothelial dysfunction and coagulation at baseline in these patients. The increased levels of sP‐sel immediately post procedure and at 24 h, in association with increased vWf levels at 24 h after PBMVP, are in keeping with an increase in platelet activation and endothelial dysfunction following PBMVP. These changes may contribute to the increased risk of thromboembolism following PBMVP and suggest the need for adequate antithrombotic therapy following PBMVP.
Keywords: mitral valve, valvuloplasty, atrial fibrillation, endothelial dysfunction, fibrinogen, von Willebrand factor
Full Text
The Full Text of this article is available as a PDF (452.9 KB).
References
- 1. A report from the National Heart, Lung and Blood Institute Balloon Valvuloplasty Registry: Complications and mortality of percutaneous balloon mitral commissurotomy. Circulation 1992; 85: 2014–2024 [DOI] [PubMed] [Google Scholar]
- 2. Arora R, Nair M, Kalra GS, Nigam M, Khalilullah M: Immediate and long term results of balloon and surgical closed mitral valvotomy: A randomized comparative study. Am Heart J 1993; 125: 1091–1095 [DOI] [PubMed] [Google Scholar]
- 3. Ionue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N: Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984; 87: 394–402 [PubMed] [Google Scholar]
- 4. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S: Smoke‐like echo in the left atrial cavity in mitral valve disease: Its features and significance. J Am Coll Cardiol 1985; 6: 744–749 [DOI] [PubMed] [Google Scholar]
- 5. Daniel WG, Nellessen U, Schroder E, Nonnast‐Daniel B, Bednarski P, Nikutta P, Lichtlen PR: Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988; 11: 1204–1211 [DOI] [PubMed] [Google Scholar]
- 6. Harris AW, Levine SA: Cerebral emboli in mitral stenosis. Ann Intern Med 1941; 51: 637–643 [Google Scholar]
- 7. Garvin CF: Mural thrombi in the heart. Am Heart J 1941; 21: 713–720 [Google Scholar]
- 8. Ullal SR, Kluge TH, Hill JD, Keith WJ, Gerbode F: Left atrial thrombi in mitral valve disease. J Thorac Cardiovasc Surg 1971; 62: 932–937 [PubMed] [Google Scholar]
- 9. Braunwald E: Valvular heart disease In Heart Disease. A Textbook of Cardiovascular Medicine (Ed. Braunwald E.), p. 1095–1165. Philadelphia, London, Toronto: WB Saunders, 1980. [Google Scholar]
- 10. Yamamoto K, Ikeda U, Seino Y, Mito H, Fujikawa H, Sekiguchi H, Shimada K: Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol 1995; 25: 107–112 [DOI] [PubMed] [Google Scholar]
- 11. Lip GYH, Blann A: Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997; 34: 255–265 [DOI] [PubMed] [Google Scholar]
- 12. Lip GYH, Lowe GDO, Rumley A, Dunn FG: Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin treatment. Br Heart J 1995; 73: 527–533 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343–350 [PubMed] [Google Scholar]
- 14. Gough SCL, Prentice CRM: The investigation of a heart valve patient with suspected hypercoagulability. J Heart Valve Dis 1993; 2: 7–17 [PubMed] [Google Scholar]
- 15. Harker LA, Hanson SR: Platelet factors predisposing to arterial thrombosis. Bailliere's Clin Haematol 1994; 7: 499–521 [DOI] [PubMed] [Google Scholar]
- 16. Michelson AD: Flow cytometry: A clinical test of platelet function. Blood 1996; 87: 4925–4936 [PubMed] [Google Scholar]
- 17. Konstantopoulos K, Wu KK, Udden MM, Banez EI, Shattil SJ, Hellums JD: Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology 1995: 32: 73–93 [DOI] [PubMed] [Google Scholar]
- 18. Penny WF, Weinstein M, Salzman EW, Ware JA: Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation 1991; 83: 1630–1636 [DOI] [PubMed] [Google Scholar]
- 19. Yamamoto K, Ikeda U, Minezaki KK, Fukazawa H, Mizuno O, Seungbum Kim, Fujikawa H, Swkiguchi H, Shimada K: Effect of mitral valvuloplasty in mitral stenosis on coagulation activity. Am J Cardiol 1997; 779: 1131–1135 [DOI] [PubMed] [Google Scholar]
- 20. Parvez Z, Khan T, Moncada R: Ultrastructural changes in rat aortic endothelium during contrast media infusion. Invest Radiol 1985; 20: 407–412 [DOI] [PubMed] [Google Scholar]
- 21. Albanese JR: Effects of ionic and non‐ionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 1995; 76: [DOI] [PubMed] [Google Scholar]